Hong K. Ha
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Wash-Free Digital Detection of Tumor Extracellular Vesicles via Plasmonic Droplet Microfluidics.
Journal: ACS sensors
Published: April 21, 2026
Comparison of Long-Term Oncological Outcomes of Intravesical Bacillus Calmette-Guérin Versus Gemcitabine in Treatment-Naïve Non-Muscle-Invasive Bladder Cancer with Intermediate and High Risk: A Multicenter Retrospective Analysis.
Journal: Journal of clinical medicine
Published: March 15, 2026
Treatment strategies for cisplatin-ineligible metastatic bladder cancer: Emerging therapies and future perspectives.
Journal: Investigative and clinical urology
Published: July 09, 2025
Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients.
Journal: Investigative and clinical urology
Published: July 08, 2025
Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study.
Journal: Investigative and clinical urology
Published: March 31, 2025
Urinary DNA Methylation Test for Bladder Cancer Diagnosis.
Journal: JAMA oncology
Published: January 30, 2025
Real-World Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-muscle-Invasive Bladder Cancer.
Journal: Cancer research and treatment
Published: January 23, 2025
Artificial intelligence-driven digital pathology in urological cancers: current trends and future directions.
Journal: Prostate international
Published: January 03, 2025
Clinical implications of deep learning based image analysis of whole radical prostatectomy specimens.
Journal: Scientific reports
Published: December 25, 2024
Incidence and management of hepatic immune‑related adverse events in advanced urologic cancers treated with immune checkpoint inhibitors: A multicenter retrospective study.
Journal: Oncology letters
Published: October 17, 2024
Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study.
Journal: Investigative and clinical urology
Published: September 08, 2024
Impact of diabetes mellitus and hypertension on renal function during first-line targeted therapy for metastatic renal cell carcinoma: a retrospective multicenter study.
Journal: Translational andrology and urology
Published: May 11, 2024
Last Updated: 09/26/2026